Current Report Filing (8-k)
October 05 2022 - 7:02AM
Edgar (US Regulatory)
0000727346
false
0000727346
2022-10-04
2022-10-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 4, 2022
SELECTIS
HEALTH, INC.
(Exact
Name of Registrant as Specified in its Charter)
Utah |
|
0-15415 | |
87-0340206 |
(State
or other jurisdiction |
|
Commission
File |
|
(I.R.S.
Employer |
of
incorporation) |
|
Number |
|
Identification
number) |
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO |
|
80111 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐ |
Written
communications pursuant to Rule 425 under the Securities Act |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
4.01. CHANGES IN REGISTRANT’S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
(a)
Change of Independent Registered Public Accounting Firm
Effective
October 4, 2022, the Company’s Board of Directors, at the recommendation of the Audit Committee that has been separately appointed,
approved a change of the Company’s independent registered public accountants. The Company’s former independent auditors,
Haynie & Company, audited the Company’s financial statements for the year ended December 31, 2021.
In
the period from Haynie & Company’s appointment in 2022 until the date of this Report, there were no disagreements with Haynie
& Company on any matters of accounting principles or practices, financial statement disclosure, or auditing scope and procedures
which, if not resolved to the satisfaction of Haynie & Company, would have caused Haynie & Company to make reference to the matter
in its report on the Company’s financial statements; and there were no reportable events as defined in Item 304(a)(1)(v) of Regulation
S-K except for the material weaknesses described in Item 9A of the Company’s Annual Report on Form 10-K for the year ended December
31, 2021. Haynie & Company issued an audit report on our consolidated financial statements as of and for the year ended December
31, 2021, which did not contain any adverse opinion or disclaimer of opinion nor was qualified or modified as to any uncertainty, audit
scope or accounting principle.
The
Company has provided Haynie & Company with a copy of the above disclosures. Attached as Exhibit 16.1 is a copy of Haynie & Company,
LLP’s letter, dated October 4, 2022, stating its agreement with such statements.
(b)
Newly Engaged Independent Registered Public Accounting Firm
Effective
October 4, 2022, the Company’s Board of Directors, at the recommendation of the Audit Committee that has been separately appointed,
approved the appointment of Marcum LLP to serve as the Company’s independent registered public accounting firm. Prior to its engagement
as the Company’s independent registered public accounting firm the Company had not consulted Marcum LLP with respect to the application
of accounting principles to specific transactions or the type of audit opinion that might be rendered on the Company’s financial
statements. Marcum LLP will also be performing the Company’s tax preparation for calendar year 2022.
The
Company engaged Marcum LLP because of their market dominance in the senior healthcare industry, its expertise in the industry and its
resources available to ensure timely filings and annual audits. Marcum LLP is ranked number ten after its merger with Friedman LLP on
Accounting Today’s list of the top 100 firms with over $1 billion in annual revenue and more than 3,400 associates. The engagement
of Marcum LLP was effective on October 4, 2022.
Item
9.01 Financial Statements and Exhibits
(a) Financial statements of businesses
acquired.
Not applicable
(b) Pro forma financial information.
Not
applicable
(c) Shell company transactions.
Not
applicable
(d) Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
Selectis
Health, Inc. |
|
(Registrant) |
|
|
Dated:
October 5, 2022 |
/s/
Lance Baller |
|
Lance
Baller, CEO |
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jul 2023 to Jul 2024